the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Regulation Market Research Reports

 

We offer market research, industry forecasts, and business analysis in the Regulation Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
The 111th U.S. Congress Tackles Healthcare Reform and the Pharmaceutical Industry
Table of Contents Published: 2009/09 Published by: Decision Resources, Inc.
The stakes have never been higher or more serious for the pharmaceutical industry - a perfect storm of legislation is moving through Washington, D.C., to address patent reform, healthcare reform, drug importation, authorized generics, biosimilars, and muc ...

The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
Table of Contents Published: 2009/09 Published by: Business Insights
The Middle East pharmaceutical market is diverse, with a significant presence of leading global players alongside domestic pharmaceutical companies such as Ibrahim, Bilim and Deva. ...

Algeria Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In BMI's Q409 Business Environment Rankings matrix for the 17 key countries of the Middle East and Africa (MEA) region, Algeria remains in a lowly 14th position. ...

Argentina Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
BMI calculates Argentina's pharmaceutical expenditure to have been ARS11.56bn (US$3.73bn) in 2008. ...

Australia Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In 2008, Australia's pharmaceutical market was worth US$6.93bn, it is forecast to reach US$7.28bn in 2009 and rise to over US$10bn in 2013, which represents a compound annual growth rate (CAGR) of 7.72. ...

Bangladesh Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
Of the 15 key markets surveyed in BMI's Pharmaceuticals & Healthcare Business Environment Rankings, Bangladesh is placed in 14th position, and can be found above Vietnam, the latter being judged the least attractive proposition for investment. ...

Chinese Pharmaceutical Market Outlook 2009-2024
Table of Contents Published: 2009/08 Published by: Visiongain
This report - Chinese Pharmaceutical Market Outlook 2009-2024 - analyses prospects for the pharma market and industry sector in China. This new study discusses market drivers and restraints such as production capacity, intellectual property rights and the ...

Croatia Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In the BMI's Q409 Pharmaceuticals & Healthcare Business Environment Rankings (BER) for Central and Eastern Europe (CEE), Croatia is once again 10th of the 20 regional markets surveyed. ...

France Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In BMI's Business Environment Rankings (BER) for Q409, France remains ranked 3rd out of the 9 Western European markets surveyed. ...

Hungary Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In BMI's Business Environment Ratings (BER) for Q409, Hungary remains ranked 11th, out of the 20 major markets within Central and Eastern Europe (CEE), its position having worsened in recent months. ...

Indonesia Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In BMI's Business Environment Rating matrix for Q409, Indonesia once again occupies 12th position, out of the 15 regional markets surveyed in the Asia Pacific region. ...

Jordan Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
BMI's new Pharmaceutical & Healthcare Report for Q409 forecasts that the value of the Jordanian drug market will increase from around JOD263mn (US$370mn) in 2008 to JOD369mn (US$519mn) by 2013. ...

Kenya Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
BMI calculates Kenya's pharmaceutical expenditure to have been KES15.85bn (US$229mn) in 2008. ...

Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009
Table of Contents Published: 2009/08 Published by: Decision Resources, Inc.
The second quarter of 2009 saw steady progress toward healthcare reform in the United States and action in several of the world' s other major pharmaceutical markets to curb pharmaceutical expenditures. ...

Mexico Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
Our forecasts reveal a modest compound annual growth rate (CAGR) of around 9.7% in US dollar terms for Mexico's total drug market value, which is forecast to reach US$15.7bn by 2013. ...

Morocco Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
BMI expects the drug market in Morocco to increase in value from US$1.38bn in 2008 to US$1.88bn in 2013, representing a compound annual growth rate (CAGR) of 5.5% in US dollar terms. ...

Nigeria Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
For BMI's Q409 Nigeria Pharmaceutical and Healthcare report, we expect total drug market spending in the country to rise from US$633mn in 2008 to US$695mn by 2013, representing a compound annual growth rate (CAGR) of 1.59% in US dollar terms and 3.24% i ...

Oman Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In the Q409 BMI's Business Environment Ranking (BER) matrix for Middle East and Africa (MEA), Oman is placed seventh, having improved its position by three places in relation to the previous quarter. ...

Pakistan Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In BMI's Business Environment Rankings (BER) matrix for Q409, Pakistan slightly improved its position, now ranking joint 13th out of the 15 markets assessed in the Asia Pacific region. ...

Poland Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
the third-largest market in Central and Eastern Europe (CEE), on face value Poland remains one of the biggest opportunities for multinational pharmaceutical companies. ...

Serbia Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In the BMI's Q409 Business Environment Rating (BER) matrix, Serbia continued to improve its placement, and is now found in 9th position, out of the 20 key markets surveyed in the Emerging Europe region. ...

Slovenia Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
Slovenia is ranked in 9th position in BMI's Business Environment Ratings for Central and Eastern Europe (CEE) in Q409, highlighting it as a reasonably attractive investment opportunity for drugmakers. ...

Strategic Analysis of the Healthcare Industry in Zambia
Table of Contents Published: 2009/08 Published by: Frost & Sullivan
This research service presents an in-depth analysis of the Zambian healthcare industry. It provides a general insight into processes of regulations, medical insurance, healthcare procurement and financing. ...

The Executive Guide to Worldwide Healthcare Organisation
Table of Contents Published: 2009/08 Published by: Espicom Business Intelligence
Barack Obama' s plans for healthcare reform in the US have generated a great deal of controversy, with opponents appalled at what they see as an increasing tax burden and over involvement of the state. In contrast, the UK' s NHS provides a comprehensive s ...

The Pharmaceutical Market: South Korea
Table of Contents Published: 2009/08 Published by: Espicom Business Intelligence
Espicom' s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. ...

Turkey Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
In BMI's regional Pharmaceutical & Healthcare Business Environment Rankings (BER) for Q409, Turkey's score dropped relative to the previous two quarters. ...

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
Recent months have shown that Uzbekistan's economy remains resilient if not immune to the global financial crisis. ...

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2009
Table of Contents Published: 2009/08 Published by: Business Monitor International
There are some green shoots of hope appearing in the wreckage of Zimbabwe's healthcare sector, as a number of foreign companies are considering re-investing in the country. ...

Bahrain Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In Q309, BMI expects Bahrainfs total drug market value to increase from US$115mn, in 2008, to US$118mn by 2013, with a compound annual growth rate (CAGR) of only 0.52% in US dollar terms. ...

Belgium Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In BMIfs latest pharmaceutical market report for Belgium, we are forecasting flat value growth for Belgiumfs pharmaceutical market. ...

Brazil Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In terms of emerging pharmaceutical markets, Brazil remains one of the most attractive to multinational pharmaceutical companies operating in the Americas. ...

Chile Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Chile Pharmaceuticals and Healthcare Report Q3 2009. ...

China Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
For the Q309 update of BMI's China Pharmaceuticals & Healthcare report, we have maintained our topline forecast for medicine expenditure in the world's most populous country, as no new sales figures have emerged and the country's macroeconomic projectio ...

Czech Republic Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
The Czech pharmaceutical market is among the most developed in Central and Eastern Europe (CEE). ...

Hungary Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
BMI has downgraded its forecast for Hungaryfs US$3.28bn pharmaceutical market after the macroeconomic climate deteriorated further in Q209. ...

Indonesia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Indonesia Pharmaceuticals and Healthcare Report Q3 2009. ...

Japan Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In 2009, the value of Japan's pharmaceutical market is expected to only grow marginally, as price cuts and the growth of generic substitution impact pharmaceutical expenditure. ...

Lithuania Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Total drug market expenditure in Lithuania will be affected heavily by the depreciation in local currency against the US dollar. ...

Malaysia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Malaysia Pharmaceuticals and Healthcare Report Q3 2009. ...

Moldova Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Moldovafs pharmaceutical market was valued at only US$242mn in 2008, making the country of minimal attractiveness to all but the most pan-European multinational pharmaceutical companies. ...

Portugal Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Portugal Pharmaceuticals and Healthcare Report Q3 2009. ...

Pricing and Reimbursement: Innovative Risk-Sharing Strategies
Table of Contents Published: 2009/07 Published by: Datamonitor
Novel niche biologics entering the market require high price points in order to provide manufacturers with a return on investment. However, with heightening regulatory scrutiny and increasing cost-pressures, a balance must be struck between incentivizing ...

Romania Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Romania places sixth among the 20 key markets surveyed as a part of BMI's Pharmaceuticals & Healthcare Business Environment Rankings, and can be found between Turkey and Estonia. ...

Russia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Russia's overall macroeconomic situation has stabilised markedly since the end of Q109 ? most notably as the ruble's managed devaluation earlier in the year did not turn into a rout for the currency, or consume all of the country's stability fund. Still ...

Spain Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Spainfs pharmaceutical market, valued at EUR15.3bn in 2008, is expected to be cushioned from the impact of the global financial crisis in the short term, with BMI forecasting nominal drug market expenditure growth of 6% in euros between 2008 and 2009. ...

Switzerland Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Switzerland Pharmaceuticals and Healthcare Report Q3 2009. ...

The Chinese Hospital Pharmaceutical Market Outlook To 2014: Policy environment, healthcare system, market structure, competitive landscape, growth opportunities
Table of Contents Published: 2009/07 Published by: Business Insights
The Chinese Hospital Pharmaceutical Market Outlook to 2014' provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and includes detailed epidemiological analyses of the common risk fac ...

The SADC Healthcare Regulatory Environment
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service identifies and discusses the regulatory framework (including that of medical waste management and medical insurance) of the Southern African Development Communities (SADC) countries. ...

Ukraine Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Ukraine Pharmaceuticals and Healthcare Report Q3 2009. ...

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
The UAE Ministry of Health is planning to establish a National Pharmocovigilance Committee in Q309. ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.